Cargando…

Survival Outcomes in T3 Laryngeal Cancers: Primary Total Laryngectomy vs. Concurrent Chemoradiation or Radiation Therapy—A Meta-Analysis †

Background: The management of cT3 laryngeal cancers remains controversial, with studies recommending surgical or non-surgical approaches. Despite the many papers that have been published on the subject, there is a lack of studies showing which treatment has better results in terms of survival. Objec...

Descripción completa

Detalles Bibliográficos
Autores principales: Rao, Karthik Nagaraja, Pai, Prathamesh S., Dange, Prajwal, Kowalski, Luiz P., Strojan, Primož, Mäkitie, Antti A., Guntinas-Lichius, Orlando, Robbins, K. Thomas, Rodrigo, Juan P., Eisbruch, Avraham, Takes, Robert P., de Bree, Remco, Coca-Pelaz, Andrés, Piazza, Cesare, Chiesa-Estomba, Carlos, López, Fernando, Saba, Nabil F., Rinaldo, Alessandra, Ferlito, Alfio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10452463/
https://www.ncbi.nlm.nih.gov/pubmed/37626625
http://dx.doi.org/10.3390/biomedicines11082128
_version_ 1785095677427056640
author Rao, Karthik Nagaraja
Pai, Prathamesh S.
Dange, Prajwal
Kowalski, Luiz P.
Strojan, Primož
Mäkitie, Antti A.
Guntinas-Lichius, Orlando
Robbins, K. Thomas
Rodrigo, Juan P.
Eisbruch, Avraham
Takes, Robert P.
de Bree, Remco
Coca-Pelaz, Andrés
Piazza, Cesare
Chiesa-Estomba, Carlos
López, Fernando
Saba, Nabil F.
Rinaldo, Alessandra
Ferlito, Alfio
author_facet Rao, Karthik Nagaraja
Pai, Prathamesh S.
Dange, Prajwal
Kowalski, Luiz P.
Strojan, Primož
Mäkitie, Antti A.
Guntinas-Lichius, Orlando
Robbins, K. Thomas
Rodrigo, Juan P.
Eisbruch, Avraham
Takes, Robert P.
de Bree, Remco
Coca-Pelaz, Andrés
Piazza, Cesare
Chiesa-Estomba, Carlos
López, Fernando
Saba, Nabil F.
Rinaldo, Alessandra
Ferlito, Alfio
author_sort Rao, Karthik Nagaraja
collection PubMed
description Background: The management of cT3 laryngeal cancers remains controversial, with studies recommending surgical or non-surgical approaches. Despite the many papers that have been published on the subject, there is a lack of studies showing which treatment has better results in terms of survival. Objective: To determine the difference in survival outcomes following total laryngectomy (TL), concurrent chemoradiation (CRT) or radiation therapy (RT) alone in T3 laryngeal cancers. Methods: Search of PubMed, Scopus, and Google Scholar databases from 1995 to 2023 employing specific keywords and Boolean operators to retrieve relevant articles. Statistical analysis was conducted using a random-effects model, and heterogeneity was evaluated using the Q-test and I(2) statistic. Funnel plot asymmetry was assessed using rank correlation and regression tests. Results: The qualitative data synthesis comprised 10,940 patients from 16 included studies. TL was performed in 2149 (19.4%), CRT in 6723 (61.5%), RT in 295 (2.7%), while non-surgical treatment was not specified in 1773 (16.2%) patients. The pooled 2-year overall survival (OS) rates were TL = 73%, CRT = 74.7%, RT = 57.9%, 3-year OS rates were TL = 64.3%, CRT = 62.9%, RT = 52.4%, and 5-year OS rates were TL = 54.2%, CRT = 52.7%, RT = 40.8%. There was a significant heterogeneity in the included studies. There was no statistically significant difference in 2-year OS (logOR= −0.88 (95% confidence interval (CI): −1.99 to 0.23), p = 0.12), 3-year OS (logOR = −0.6 (95% CI: −1.34 to 0.15), p = 0.11), and 5-year OS (logOR = −0.54 (95% CI: −1.29 to 0.21), p = 0.16) between TL and CRT. Instead, there was significant difference in 2-year OS (logOR= −1.2383 (95% CI: −2.1679 to −0.3087), p = 0.009), 3-year OS (−1.1262 (95% CI: −1.6166 to −0.6358), p < 0.001), and 5-year OS (−0.99 (95% CI: −1.44 to −0.53)), p < 0.001) between TL and RT alone. Conclusions and Significance: TL followed with adjuvant (chemo)radiation on indication and CRT with salvage surgery in reserve appear to have similar OS outcomes. Both resulted in better OS outcomes compared to RT alone in the treatment of T3 laryngeal cancers. If patients are unfit for chemotherapy, making CRT impossible, surgery may become the choice of treatment.
format Online
Article
Text
id pubmed-10452463
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-104524632023-08-26 Survival Outcomes in T3 Laryngeal Cancers: Primary Total Laryngectomy vs. Concurrent Chemoradiation or Radiation Therapy—A Meta-Analysis † Rao, Karthik Nagaraja Pai, Prathamesh S. Dange, Prajwal Kowalski, Luiz P. Strojan, Primož Mäkitie, Antti A. Guntinas-Lichius, Orlando Robbins, K. Thomas Rodrigo, Juan P. Eisbruch, Avraham Takes, Robert P. de Bree, Remco Coca-Pelaz, Andrés Piazza, Cesare Chiesa-Estomba, Carlos López, Fernando Saba, Nabil F. Rinaldo, Alessandra Ferlito, Alfio Biomedicines Review Background: The management of cT3 laryngeal cancers remains controversial, with studies recommending surgical or non-surgical approaches. Despite the many papers that have been published on the subject, there is a lack of studies showing which treatment has better results in terms of survival. Objective: To determine the difference in survival outcomes following total laryngectomy (TL), concurrent chemoradiation (CRT) or radiation therapy (RT) alone in T3 laryngeal cancers. Methods: Search of PubMed, Scopus, and Google Scholar databases from 1995 to 2023 employing specific keywords and Boolean operators to retrieve relevant articles. Statistical analysis was conducted using a random-effects model, and heterogeneity was evaluated using the Q-test and I(2) statistic. Funnel plot asymmetry was assessed using rank correlation and regression tests. Results: The qualitative data synthesis comprised 10,940 patients from 16 included studies. TL was performed in 2149 (19.4%), CRT in 6723 (61.5%), RT in 295 (2.7%), while non-surgical treatment was not specified in 1773 (16.2%) patients. The pooled 2-year overall survival (OS) rates were TL = 73%, CRT = 74.7%, RT = 57.9%, 3-year OS rates were TL = 64.3%, CRT = 62.9%, RT = 52.4%, and 5-year OS rates were TL = 54.2%, CRT = 52.7%, RT = 40.8%. There was a significant heterogeneity in the included studies. There was no statistically significant difference in 2-year OS (logOR= −0.88 (95% confidence interval (CI): −1.99 to 0.23), p = 0.12), 3-year OS (logOR = −0.6 (95% CI: −1.34 to 0.15), p = 0.11), and 5-year OS (logOR = −0.54 (95% CI: −1.29 to 0.21), p = 0.16) between TL and CRT. Instead, there was significant difference in 2-year OS (logOR= −1.2383 (95% CI: −2.1679 to −0.3087), p = 0.009), 3-year OS (−1.1262 (95% CI: −1.6166 to −0.6358), p < 0.001), and 5-year OS (−0.99 (95% CI: −1.44 to −0.53)), p < 0.001) between TL and RT alone. Conclusions and Significance: TL followed with adjuvant (chemo)radiation on indication and CRT with salvage surgery in reserve appear to have similar OS outcomes. Both resulted in better OS outcomes compared to RT alone in the treatment of T3 laryngeal cancers. If patients are unfit for chemotherapy, making CRT impossible, surgery may become the choice of treatment. MDPI 2023-07-28 /pmc/articles/PMC10452463/ /pubmed/37626625 http://dx.doi.org/10.3390/biomedicines11082128 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Rao, Karthik Nagaraja
Pai, Prathamesh S.
Dange, Prajwal
Kowalski, Luiz P.
Strojan, Primož
Mäkitie, Antti A.
Guntinas-Lichius, Orlando
Robbins, K. Thomas
Rodrigo, Juan P.
Eisbruch, Avraham
Takes, Robert P.
de Bree, Remco
Coca-Pelaz, Andrés
Piazza, Cesare
Chiesa-Estomba, Carlos
López, Fernando
Saba, Nabil F.
Rinaldo, Alessandra
Ferlito, Alfio
Survival Outcomes in T3 Laryngeal Cancers: Primary Total Laryngectomy vs. Concurrent Chemoradiation or Radiation Therapy—A Meta-Analysis †
title Survival Outcomes in T3 Laryngeal Cancers: Primary Total Laryngectomy vs. Concurrent Chemoradiation or Radiation Therapy—A Meta-Analysis †
title_full Survival Outcomes in T3 Laryngeal Cancers: Primary Total Laryngectomy vs. Concurrent Chemoradiation or Radiation Therapy—A Meta-Analysis †
title_fullStr Survival Outcomes in T3 Laryngeal Cancers: Primary Total Laryngectomy vs. Concurrent Chemoradiation or Radiation Therapy—A Meta-Analysis †
title_full_unstemmed Survival Outcomes in T3 Laryngeal Cancers: Primary Total Laryngectomy vs. Concurrent Chemoradiation or Radiation Therapy—A Meta-Analysis †
title_short Survival Outcomes in T3 Laryngeal Cancers: Primary Total Laryngectomy vs. Concurrent Chemoradiation or Radiation Therapy—A Meta-Analysis †
title_sort survival outcomes in t3 laryngeal cancers: primary total laryngectomy vs. concurrent chemoradiation or radiation therapy—a meta-analysis †
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10452463/
https://www.ncbi.nlm.nih.gov/pubmed/37626625
http://dx.doi.org/10.3390/biomedicines11082128
work_keys_str_mv AT raokarthiknagaraja survivaloutcomesint3laryngealcancersprimarytotallaryngectomyvsconcurrentchemoradiationorradiationtherapyametaanalysis
AT paiprathameshs survivaloutcomesint3laryngealcancersprimarytotallaryngectomyvsconcurrentchemoradiationorradiationtherapyametaanalysis
AT dangeprajwal survivaloutcomesint3laryngealcancersprimarytotallaryngectomyvsconcurrentchemoradiationorradiationtherapyametaanalysis
AT kowalskiluizp survivaloutcomesint3laryngealcancersprimarytotallaryngectomyvsconcurrentchemoradiationorradiationtherapyametaanalysis
AT strojanprimoz survivaloutcomesint3laryngealcancersprimarytotallaryngectomyvsconcurrentchemoradiationorradiationtherapyametaanalysis
AT makitieanttia survivaloutcomesint3laryngealcancersprimarytotallaryngectomyvsconcurrentchemoradiationorradiationtherapyametaanalysis
AT guntinaslichiusorlando survivaloutcomesint3laryngealcancersprimarytotallaryngectomyvsconcurrentchemoradiationorradiationtherapyametaanalysis
AT robbinskthomas survivaloutcomesint3laryngealcancersprimarytotallaryngectomyvsconcurrentchemoradiationorradiationtherapyametaanalysis
AT rodrigojuanp survivaloutcomesint3laryngealcancersprimarytotallaryngectomyvsconcurrentchemoradiationorradiationtherapyametaanalysis
AT eisbruchavraham survivaloutcomesint3laryngealcancersprimarytotallaryngectomyvsconcurrentchemoradiationorradiationtherapyametaanalysis
AT takesrobertp survivaloutcomesint3laryngealcancersprimarytotallaryngectomyvsconcurrentchemoradiationorradiationtherapyametaanalysis
AT debreeremco survivaloutcomesint3laryngealcancersprimarytotallaryngectomyvsconcurrentchemoradiationorradiationtherapyametaanalysis
AT cocapelazandres survivaloutcomesint3laryngealcancersprimarytotallaryngectomyvsconcurrentchemoradiationorradiationtherapyametaanalysis
AT piazzacesare survivaloutcomesint3laryngealcancersprimarytotallaryngectomyvsconcurrentchemoradiationorradiationtherapyametaanalysis
AT chiesaestombacarlos survivaloutcomesint3laryngealcancersprimarytotallaryngectomyvsconcurrentchemoradiationorradiationtherapyametaanalysis
AT lopezfernando survivaloutcomesint3laryngealcancersprimarytotallaryngectomyvsconcurrentchemoradiationorradiationtherapyametaanalysis
AT sabanabilf survivaloutcomesint3laryngealcancersprimarytotallaryngectomyvsconcurrentchemoradiationorradiationtherapyametaanalysis
AT rinaldoalessandra survivaloutcomesint3laryngealcancersprimarytotallaryngectomyvsconcurrentchemoradiationorradiationtherapyametaanalysis
AT ferlitoalfio survivaloutcomesint3laryngealcancersprimarytotallaryngectomyvsconcurrentchemoradiationorradiationtherapyametaanalysis